Liquid Structure™ Technology
Research Team
MARK J. ROSENFELD, M.S., Ph.D
Chief Executive Officer & Chief Science Officer, Ananda Scientific
- US Scientist, Joint United Nations FAO/IAEA Committee on Transboundary Diseases (innovated a device for the molecular detection of bird flu and other influenzas)
- Visiting Scholar, Giant Panda Conservation and Research Center, Peking University, China
- Faculty, Molecular Biology, University of Utah School of Medicine
- Consultant, Cannabis Legalization and Regulatory Affairs to Multiple States
NISSIM GARTI, M.S., Ph.D.
Scientific & Technical Research Partner, Ananda Scientific
- Director, Casali Institute of Applied Chemistry, The Hebrew University of Jerusalem
- Search Committee, 2013 Nobel Prize in Chemistry
- Recipient 2016 Herjie Award (global award for nanotechnology research excellence)
- The Japanese Award for the Promotion of Senior Foreign Scientists
- Ratner Chair of Chemistry of the Hebrew University
PERRY G. FINE, M.D.
Medical Director, Ananda Scientific
- President Emeritus, American Academy of Pain Medicine
- Member, FDA Advisory Board for Opioids
- Chair, National Initiative on Pain Control
- Board of Directors, American Academy of Pain Medicine
- Board of Directors, American Pain Foundation
- Consultant, Cannabis Legalization and Regulatory Affairs to Multiple States
Jacobi (Kobi) Atsmon, M.D.
Clinical Trials Director, Ananda Scientific
- Managing Director, Early Phase Clinical Trials, Clinical Research Center (CRC), Tel Aviv Sourasky Medical Center, Israel
- Principal Investigator for over 300 clinical studies and considered one of the leading experts in Israel on early phase clinical trials
- Senior Lecturer, Tel Aviv University School of Medicine
SUSAN ALPERT, M.D., Ph.D.
Regulatory Affairs & Clinical Trials Advisor, Ananda Scientific
- Director, USFDA Office of Device Evaluation
- Senior Vice President − Global Regulatory Affairs, Medtronic
- Vice President − Regulatory Sciences, C.R. Baird, Inc.
- Chairman, Regulatory Affairs Professionals Society
- Advisory Board, Medical Technology Leadership Forum
- Executive Committee, Clinical Trials Transformation Initiative
MARK M. COHEN, MBBS (Hons), PhD, FAMAC, FICAE
Wellness & Sports Medicine, Ananda Scientific
- Chairman, Wellness Program,, Royal Melbourne Institute of Technology (RMIT University), Australia
- Director, Centre for Complementary Medicine, Institute for Health Services Research, Monash University, Australia
- Expert Advisor, Australia Therapeutics Good Authority Complementary Medicine Evaluation Committee
Michael Dor MD, MPA
Medical Advisor – Cannabinoids, Ananda Scientific
- Medical Director, Medical Cannabis Unit, Israel Health Ministry
- Recipient, Presidential Award (highest Israel civilian honor)
- Head, Hospitals Division, Israel Health Ministry
- Head, General Medicine Division, Israel Health Ministry
- Deputy Director, Health Management, Israel Health Ministry
Silviu Brill, MD
Phase 2 Clinical Director – Neuropathic Pain, Ananda Scientific
- Director, Pain Center, Tel Aviv Sourasky Medical Center
- Professor, Faculty of Medicine, Ben Gurion University
- President Emeritus, Israel Pain Association
- President Emeritus, Pain Section, Israel Society of Anesthesiology
- Member, European Pain Federation Task Force on Cannabis Based Medicine
DAVID E. MOODY, PhD
Cannabinoid Analytics – Bioassays, Ananda Scientific
- Chairman, Pharmacology and Toxicology Department, School of Pharmacy, University of Utah
- Inspector. National Laboratory Certification Program
- Developed and implemented the cannabinoid tests for bodily fluids used by the USFDA, US Drug Enforcement Agency and National Institute of Drug Abuse
- Grant Reviewer, Neuropharmacology, NIH Center for Review